Setting the tumor volume of the control group to 100%, the tumor volumes of the KS-133 NPs/anti-PD-1 antibody and KS-133(P3S) NPs/anti-PD-1 antibody groups were 30% and 55%, respectively. This evidence concerns the gene PDCD1 and neoplasm.